October 28th 2024, 4:29pm
Panelists discuss how assessing patients' responses to treatment and addressing common adverse effects are essential for effective management of advanced prostate cancer, while also highlighting the importance of patient education and preparation before starting therapy.
October 28th 2024, 1:00pm
An expert discussed how liquid and tissue biopsies can help monitor treatment and detect potential resistance in patients with non-small cell lung cancer.
October 26th 2024, 2:00pm
Through regular follow-ups and symptom assessments, breast cancer survivors have the access to physical and emotional support they may need.
October 25th 2024, 1:00pm
Patients undergoing transoral robotic surgery or radiation for oropharyngeal cancer should try to eat during treatment to maintain swallowing muscles.
October 24th 2024, 9:00pm
An expert explained the advantages and disadvantages of radiation as a treatment for patients with renal cell carcinoma, a type of kidney cancer.
October 22nd 2024, 2:06pm
The panel concludes with Danielle Hicks sharing where viewers can go to learn more about the information and resources discussed in the panel, including safety information. Sponsored by Bristol Myers Squibb.
October 22nd 2024, 2:05pm
Danielle Hicks, a patient advocate, details her journey as a caregiver for her mother and provides advice for other caring for loved ones with lung cancer. Sponsored by Bristol Myers Squibb.
October 22nd 2024, 2:04pm
Danielle Hicks, Nisha Mohindra, MD, and Christopher Towe, MD, share their perspectives and offer advice to those navigating an early-stage non-small cell lung cancer diagnosis. Sponsored by Bristol Myers Squibb.
October 22nd 2024, 2:03pm
Nisha Mohindra, MD, and Christopher Towe, MD, define the term “multidisciplinary team” and explain why early-stage NSCLC care requires a diverse group of specialists. They also discuss the function and value of this collaborative model in guiding treatment plans. Sponsored by Bristol Myers Squibb.
October 22nd 2024, 2:02pm
The panel shares insights on the progress in early-stage non-small cell lung cancer treatment and the potential role of neoadjuvant therapy. Sponsored by Bristol Myers Squibb.
“Chillin’ Out” and Finding Our Cancer Community
Bavencio Maintains Bladder Cancer Benefit in Patients with Diabetes
Optimal Jakafi Dosing Associated With Improved Outcomes in Myelofibrosis
Illuminating Compassion in Cancer Care